Anti-Infective Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (RIDT, Viral Culture, DFA, Serological Assays); Application (Hospitals, Clinical Laboratories, Others), and geography

Report Code: TIPRE00021680 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Anti-infective drugs are that work to prevent or treat infections. Antibiotics, antifungals, anthelmintics, antimalarials, antiprotozoals, antituberculosis agents, and antivirals are included in this category.

MARKET DYNAMICS

Factors driving the growth of the anti-infective drugs market are the growing prevalence of infectious diseases worldwide, coupled with rising research and development activities for the development of new drugs. However, the high cost of anti-infective drugs and poor reimbursement policies is expected to hamper the growth of the market. Moreover, increasing approvals for new anti-infective drugs in nutraceutical industries and growing awareness about infectious diseases among the population are anticipated to boost the market growth.

MARKET SCOPE

The "Anti-Infective Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-infective drugs market with detailed market segmentation by drug type, route of administration, and indication. The anti-infective drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-infective drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anti-infective drugs market is segmented on the basis of drug type, route of administration, and indication. Based on drug type, the market is segmented as antibiotics, antivirals, antifungals, and others. On the basis of route of administration, the market is categorized as HIV infections, pneumonia, hepatitis, herpes simplex virus, influenza, and others. On the basis of indication, the market is categorized as oral, topical, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-infective drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-infective drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-infective drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-infective drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anti-infective drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-infective drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-infective drugs in the global market. Below mentioned is the list of few companies engaged in the anti-infective drugs market.

The report also includes the profiles of key players in anti-infective drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck & Co., Inc
  •   F. Hoffmann-La Roche Ltd
  •   Pfizer Inc
  •   Johnson & Johnson Services, Inc
  •   GlaxoSmithKline plc
  •   Hetero
  •   Mylan N.V.
  •   Aurobindo Pharma
  •   Cipla Inc
  •   Laurus Labs Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Infective Drugs Market - By Drug Type
1.3.2 Anti-Infective Drugs Market - By Route of Administration
1.3.3 Anti-Infective Drugs Market - By Indication
1.3.4 Anti-Infective Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-INFECTIVE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-INFECTIVE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI-INFECTIVE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-INFECTIVE DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI-INFECTIVE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI-INFECTIVE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIBIOTICS
7.3.1. Overview
7.3.2. Antibiotics Market Forecast and Analysis
7.4. ANTIVIRALS
7.4.1. Overview
7.4.2. Antivirals Market Forecast and Analysis
7.5. ANTIFUNGALS
7.5.1. Overview
7.5.2. Antifungals Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTI-INFECTIVE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. TOPICAL
8.4.1. Overview
8.4.2. Topical Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ANTI-INFECTIVE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. HIV INFECTIONS
9.3.1. Overview
9.3.2. HIV Infections Market Forecast and Analysis
9.4. PNEUMONIA
9.4.1. Overview
9.4.2. Pneumonia Market Forecast and Analysis
9.5. HEPATITIS
9.5.1. Overview
9.5.2. Hepatitis Market Forecast and Analysis
9.6. HERPES SIMPLEX VIRUS
9.6.1. Overview
9.6.2. Herpes simplex virus Market Forecast and Analysis
9.7. INFLUENZA
9.7.1. Overview
9.7.2. Influenza Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. ANTI-INFECTIVE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-Infective Drugs Market Overview
10.1.2 North America Anti-Infective Drugs Market Forecasts and Analysis
10.1.3 North America Anti-Infective Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anti-Infective Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Anti-Infective Drugs Market Forecasts and Analysis - By Indication
10.1.6 North America Anti-Infective Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Infective Drugs Market
10.1.6.1.1 United States Anti-Infective Drugs Market by Drug Type
10.1.6.1.2 United States Anti-Infective Drugs Market by Route of Administration
10.1.6.1.3 United States Anti-Infective Drugs Market by Indication
10.1.6.2 Canada Anti-Infective Drugs Market
10.1.6.2.1 Canada Anti-Infective Drugs Market by Drug Type
10.1.6.2.2 Canada Anti-Infective Drugs Market by Route of Administration
10.1.6.2.3 Canada Anti-Infective Drugs Market by Indication
10.1.6.3 Mexico Anti-Infective Drugs Market
10.1.6.3.1 Mexico Anti-Infective Drugs Market by Drug Type
10.1.6.3.2 Mexico Anti-Infective Drugs Market by Route of Administration
10.1.6.3.3 Mexico Anti-Infective Drugs Market by Indication
10.2. EUROPE
10.2.1 Europe Anti-Infective Drugs Market Overview
10.2.2 Europe Anti-Infective Drugs Market Forecasts and Analysis
10.2.3 Europe Anti-Infective Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anti-Infective Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Anti-Infective Drugs Market Forecasts and Analysis - By Indication
10.2.6 Europe Anti-Infective Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Infective Drugs Market
10.2.6.1.1 Germany Anti-Infective Drugs Market by Drug Type
10.2.6.1.2 Germany Anti-Infective Drugs Market by Route of Administration
10.2.6.1.3 Germany Anti-Infective Drugs Market by Indication
10.2.6.2 France Anti-Infective Drugs Market
10.2.6.2.1 France Anti-Infective Drugs Market by Drug Type
10.2.6.2.2 France Anti-Infective Drugs Market by Route of Administration
10.2.6.2.3 France Anti-Infective Drugs Market by Indication
10.2.6.3 Italy Anti-Infective Drugs Market
10.2.6.3.1 Italy Anti-Infective Drugs Market by Drug Type
10.2.6.3.2 Italy Anti-Infective Drugs Market by Route of Administration
10.2.6.3.3 Italy Anti-Infective Drugs Market by Indication
10.2.6.4 Spain Anti-Infective Drugs Market
10.2.6.4.1 Spain Anti-Infective Drugs Market by Drug Type
10.2.6.4.2 Spain Anti-Infective Drugs Market by Route of Administration
10.2.6.4.3 Spain Anti-Infective Drugs Market by Indication
10.2.6.5 United Kingdom Anti-Infective Drugs Market
10.2.6.5.1 United Kingdom Anti-Infective Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Anti-Infective Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Anti-Infective Drugs Market by Indication
10.2.6.6 Rest of Europe Anti-Infective Drugs Market
10.2.6.6.1 Rest of Europe Anti-Infective Drugs Market by Drug Type
10.2.6.6.2 Rest of Europe Anti-Infective Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Anti-Infective Drugs Market by Indication
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Infective Drugs Market Overview
10.3.2 Asia-Pacific Anti-Infective Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Infective Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anti-Infective Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Anti-Infective Drugs Market Forecasts and Analysis - By Indication
10.3.6 Asia-Pacific Anti-Infective Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Infective Drugs Market
10.3.6.1.1 Australia Anti-Infective Drugs Market by Drug Type
10.3.6.1.2 Australia Anti-Infective Drugs Market by Route of Administration
10.3.6.1.3 Australia Anti-Infective Drugs Market by Indication
10.3.6.2 China Anti-Infective Drugs Market
10.3.6.2.1 China Anti-Infective Drugs Market by Drug Type
10.3.6.2.2 China Anti-Infective Drugs Market by Route of Administration
10.3.6.2.3 China Anti-Infective Drugs Market by Indication
10.3.6.3 India Anti-Infective Drugs Market
10.3.6.3.1 India Anti-Infective Drugs Market by Drug Type
10.3.6.3.2 India Anti-Infective Drugs Market by Route of Administration
10.3.6.3.3 India Anti-Infective Drugs Market by Indication
10.3.6.4 Japan Anti-Infective Drugs Market
10.3.6.4.1 Japan Anti-Infective Drugs Market by Drug Type
10.3.6.4.2 Japan Anti-Infective Drugs Market by Route of Administration
10.3.6.4.3 Japan Anti-Infective Drugs Market by Indication
10.3.6.5 South Korea Anti-Infective Drugs Market
10.3.6.5.1 South Korea Anti-Infective Drugs Market by Drug Type
10.3.6.5.2 South Korea Anti-Infective Drugs Market by Route of Administration
10.3.6.5.3 South Korea Anti-Infective Drugs Market by Indication
10.3.6.6 Rest of Asia-Pacific Anti-Infective Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Anti-Infective Drugs Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Anti-Infective Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Anti-Infective Drugs Market by Indication
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Infective Drugs Market Overview
10.4.2 Middle East and Africa Anti-Infective Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Infective Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anti-Infective Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Anti-Infective Drugs Market Forecasts and Analysis - By Indication
10.4.6 Middle East and Africa Anti-Infective Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Infective Drugs Market
10.4.6.1.1 South Africa Anti-Infective Drugs Market by Drug Type
10.4.6.1.2 South Africa Anti-Infective Drugs Market by Route of Administration
10.4.6.1.3 South Africa Anti-Infective Drugs Market by Indication
10.4.6.2 Saudi Arabia Anti-Infective Drugs Market
10.4.6.2.1 Saudi Arabia Anti-Infective Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Anti-Infective Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Anti-Infective Drugs Market by Indication
10.4.6.3 U.A.E Anti-Infective Drugs Market
10.4.6.3.1 U.A.E Anti-Infective Drugs Market by Drug Type
10.4.6.3.2 U.A.E Anti-Infective Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Anti-Infective Drugs Market by Indication
10.4.6.4 Rest of Middle East and Africa Anti-Infective Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Anti-Infective Drugs Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Anti-Infective Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Anti-Infective Drugs Market by Indication
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Infective Drugs Market Overview
10.5.2 South and Central America Anti-Infective Drugs Market Forecasts and Analysis
10.5.3 South and Central America Anti-Infective Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anti-Infective Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Anti-Infective Drugs Market Forecasts and Analysis - By Indication
10.5.6 South and Central America Anti-Infective Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Infective Drugs Market
10.5.6.1.1 Brazil Anti-Infective Drugs Market by Drug Type
10.5.6.1.2 Brazil Anti-Infective Drugs Market by Route of Administration
10.5.6.1.3 Brazil Anti-Infective Drugs Market by Indication
10.5.6.2 Argentina Anti-Infective Drugs Market
10.5.6.2.1 Argentina Anti-Infective Drugs Market by Drug Type
10.5.6.2.2 Argentina Anti-Infective Drugs Market by Route of Administration
10.5.6.2.3 Argentina Anti-Infective Drugs Market by Indication
10.5.6.3 Rest of South and Central America Anti-Infective Drugs Market
10.5.6.3.1 Rest of South and Central America Anti-Infective Drugs Market by Drug Type
10.5.6.3.2 Rest of South and Central America Anti-Infective Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Anti-Infective Drugs Market by Indication
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI-INFECTIVE DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTI-INFECTIVE DRUGS MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO., INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. F. HOFFMANN-LA ROCHE LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JOHNSON AND JOHNSON SERVICES, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HETERO
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MYLAN N.V.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. AUROBINDO PHARMA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CIPLA INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. LAURUS LABS LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co., Inc
2. F. Hoffmann-La Roche Ltd
3. Pfizer Inc
4. Johnson & Johnson Services, Inc
5. GlaxoSmithKline plc
6. Hetero
7. Mylan N.V.
8. Aurobindo Pharma
9. Cipla Inc
10. Laurus Labs Ltd
11. Micro Labs Ltd, Inc
12. Gilead Sciences, Inc
13. Sun Pharmaceutical Industries Ltd
14. Amneal Pharmaceuticals LLC
15. Alembic Pharmaceuticals Limited
16. Lupin
17. Novartis AG
18. Zydus Pharma
19. Bausch Health
TIPRE00021680
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking